References
- Herzog C A, Ma J Z, Collins J A. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998; 339:799–805. [PUBMED], [INFOTRIEVE], [CSA]
- Mazzuchi N, Schwedt E, Fernández J M, , et al. Latin American registry of dialysis and renal transplantation: 1993 annual dialysis data report. Nephrol Dial Transplant. 1997; 12(12):2521–2527. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Teraoka S, Toma H, Nihei H, , et al. Current status of renal replacement therapy in Japan. Am J Kidney Dis. 1995; 25(1):151–164. [PUBMED], [INFOTRIEVE], [CSA]
- Mailloux L U, Bellucci A G, Napolitano B, Mossey T, Wilkes B M, Bluestone P A. Survival estimates for 683 patients starting dialysis from 1970 through 1989: identification of risk factors for survival. Clin Nephrol. 1994; 42(2):127–135. [PUBMED], [INFOTRIEVE], [CSA]
- Harris S A, Brown E A. Patients surviving more than 10 years on hemodialysis. The natural history of the complications of treatment. Nephrol Dial Transplant. 1998; 13(5):1226–1233.. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Owen W F, Madore F, Brenner B M. An observational study of cardiovascular characteristics of long-term end-stage renal disease survivors. Am J Kidney Dis. 1996; 28(6):931–936. [PUBMED], [INFOTRIEVE], [CSA]
- Wolfe R A, Gaylin D S, Port F K, Held P J, Wood C L. Using USRDS mortality tables to compare local ESRD mortality rates to national rates. Kidney Int. 1992; 42:991–996. [PUBMED], [INFOTRIEVE], [CSA]
- Brancati F L, Whelton P K, Randall B L, Neaton J D, Stamler J, Klag M J. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA. 1997; 278(23):2069–2074. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zarif L, Covic A, Iyengar S, Sehgal A R, Sedor J R, Schelling J R. Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis. Nephrol Dial Transplant. 2000; 15:1801–1807. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Caetano E RSP, Zatz R, Saldanha L B, Praxedes J N. Hypertensive nephosclerosis as a relevant cause of chronic renal failure. Hypertension. 2001; 38:171–176. [PUBMED], [INFOTRIEVE], [CSA]
- Sesso R, Fernandes P F, Ancao M, , et al. Acceptance for chronic dialysis treatment: insufficient and unequal. Nephrol Dial Transplant. 1996; 11(6):982–986. [PUBMED], [INFOTRIEVE], [CSA]
- Wolfe R A, Ashby V B, Milford E L, , et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaver transplant. N Engl J Med. 1999; 341:1725–1730. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Associação Brasileira de Transplantes de Órgãos (ABTO). Registro Brasileiro de Transplantes, 2001, São Paulo, VII Ano, No 4.
- Port F K, Wolfe R A, Mauger E A, Berling D P, Jiang K. Comparison of survival probabilities for dialysis patients vs. cadaveric renal transplant recipients. JAMA. 1993; 270:1339–1343. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lopes A A, Batista P BP, Okechukwu C N, Costa F A, Nery M M. Does the mortality risk change with years on dialysis? The Brazilian experience [Abstract A1153 from ASN/ISN World Congress of Nephrology]. Am J Kidney Dis. 2001; 12:223A. [CSA]
- Lopes A A, Batista P BP, Costa F A, Nery M M. Número de anos em tratamento dialítico crônico e risco de morte em pacientes com e sem diabetes mellitus. Rev Assoc Med Bras. 2003; 49(3):266–269. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Okechukwu C N, Lopes A A, Stack A G, Feng S, Wolfe R A, Port F K. Impact of years of dialysis therapy on mortality risk and the characteristics of longer term dialysis survivors. Am J Kidney Dis. 2002; 39(3):533–538. [PUBMED], [INFOTRIEVE], [CSA]
- Kim K, Drummond I, Ibraghimov-Beskrovnaya O, Klinger K, Arnaout M A. Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A. 2000; 97(4):1731–1736. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Griffin M D, Torres V E, Grande J P, Kumar R. Vascular expression of polycystin. J Am Soc Nephrol. 1997; 8(4):616–626. [PUBMED], [INFOTRIEVE], [CSA]
- Perrone R D, Ruthazer R, Terrin N C. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. Am J Kidney Dis. 2001; 38(4):777–784. [PUBMED], [INFOTRIEVE], [CSA]
- Prichard S S. Co morbidities and their impact on outcome in patients with end-stage renal disease. Kidney Int. 2000; 57(Suppl. 74):S100–S104. [CSA], [CROSSREF]
- Libby P, Ridker P M, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105:1135–1143. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?. Kidney Int. 2001; 59(2):407–414. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stenvinkel P, Heimbürger O, Paultre F, , et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999; 55(5):1899–1911. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999; 55(2):648–658. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]